3-D Matrix Osake

3-D Matrix EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä 3-D Matrix (7777.T) 6.8.2026 päivämäärällä on −1,16 Mrd. JPY. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −2,12 Mrd. JPY — muutos −45,39 % (korkeampi).

EBITDA

−1,16 Mrd.JPY

YoY

−45,39%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä 3-D Matrix on 2026 −1,16 Mrd. JPY. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä 3-D Matrix oli 2025 −2,12 Mrd. JPY. Se laskee −45,39% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API
Get Free API Key

3-D Matrix Osakeanalyysi

Mitä 3-D Matrix tekee? 3-D Matrix Ltd is a company specialized in the development and manufacturing of innovative products in the field of biotechnology. Since its founding in 1998, the company has gained recognition for its outstanding research and development results and is now one of the leading companies in the industry. The history of 3-D Matrix Ltd began in 1998 when a group of scientists from Japan made a groundbreaking discovery in the field of materials science. They discovered that a certain material has a unique structure that allows cells and tissues to be cultivated in a more natural way than was previously possible. This discovery formed the basis for the founding of 3-D Matrix Ltd. The business model of 3-D Matrix Ltd is to use its innovative technology and unique products in various areas of biotechnology. The company's three main divisions are regenerative medicine, cell culture, and medical devices. In the field of regenerative medicine, 3-D Matrix Ltd is working to improve the healing of tissue damage and diseases. The company has developed a range of products that enable the effective and natural regeneration of the body's own cells and tissues. These products are used in the treatment of various diseases such as diabetes, arthritis, or tumors. In the cell culture division, 3-D Matrix Ltd offers products that enable cells to be cultured in a natural and effective way. The company has developed a range of innovative cell culture products that allow cells to be grown in a three-dimensional environment that closely resembles the natural environment in the body. These products are used in drug research and development, vaccine production, and personalized medicine. In the medical devices division, 3-D Matrix Ltd offers a range of products that are used in the performance of medical procedures. These products have been developed to improve the safety and effectiveness of medical procedures while reducing recovery time. These include products such as collagen membranes, collagen sponges, and brushes, which are used in plastic surgery, dentistry, and orthopedics. Some of the products offered by 3-D Matrix Ltd include collagen membranes, collagen sponges, collagen brushes, collagen fibrils, and collagen hydrogels. All of these products have been developed using 3-D Matrix Ltd's unique material technology and provide a natural and effective solution for a variety of medical applications. In conclusion, 3-D Matrix Ltd is a company dedicated to the development and manufacturing of innovative products in the field of biotechnology. The company has developed a unique technology that allows for the natural and effective cultivation and regeneration of cells and tissues. The products of 3-D Matrix Ltd are used in various areas of biotechnology, such as regenerative medicine, cell culture, and medical devices, and provide a natural and effective solution for a variety of medical applications. 3-D Matrix on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset 3-D Matrix osakkeesta

Yhtiön 3-D Matrix EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −1,16 Mrd. JPY vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä 3-D Matrix muuttui arvosta −2,12 Mrd. JPY arvoon −1,16 Mrd. JPY, mikä edustaa −45,39 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) 3-D Matrix:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n JPY on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n 3-D Matrix historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API
Get Free API Key

Tuloslaskelma — 3-D Matrix

LiikevaihtoBruttotulosEBITEBITDANettotulosOsakekohtainen tulosMyytyjen tuotteiden kustannuksetTutkimus ja kehitysMyynti-, hallinto- ja yleiskulutKäyttökulutKorkokulutTulos ennen verojaVerokulutPoistot ja arvonalentumisetLiikevaihto per osakeEBIT per osakeLaimentunut EPSEBITDA per osakeMuut tuotot/kulut

Kaikki tunnusluvut — 3-D Matrix